Activity value 76china Buyer&Supplier,Last transaction date:
2026-05-21
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for sichuan xieli parmaceutical.co. ltd from 2025 to 2026.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2026, the company has completed 34 transactions, with a transaction quantity of 28868.2 and a transaction weight of 13724.
Product description
Hóa chất hữu cơ L-tetrahydropalmatine CAS 2934-97-6 để sản xuất L-tetrahydropalmatine hydrosulfate. Hàng mới 100%. Hàng có C/O Form E 02261418200002271
Expand
Trade date
2026/04/15
B/L No.
108152366010
Suppliers
sichuan xieli parmaceutical.co. ltd
Buyers
công ty cổ phần dược phẩm ampharco usa
POLs
——
PODs
——
Supply area
China
Purchas area
Vietnam
Weight
——
Amount
28800
Hs code
29181900
Product tags
chlorflurenol
Product description
Nguyên liệu làm thuốc - Acid Ursodeoxycholic (Ursodeoxycholic Acid). Tiêu chuẩn EP12, Lot: C092C251209, NSX: 12/25, Date: 12/28, SICHUAN XIELI PHARMACEUTICAL CO LTD. - China sx. Visa thuốc VD-26732-17
Expand
Trade date
2026/04/09
B/L No.
108133555720
Suppliers
sichuan xieli parmaceutical.co. ltd
Buyers
công ty cp dược vật tư y tế hà nam
POLs
——
PODs
——
Supply area
China
Purchas area
Vietnam
Weight
——
Amount
39900
Hs code
29329900
Product tags
——
Product description
Diosmin, tiêu chuẩn: EP11+TCNSX, số batch:C006I260301, NL dùng để sx thuốc (25kg/drum). NSX: 09/03/2026, HSD: 08/03/2031. NSX: SICHUAIN XIELI PHARMACEUTICAL CO..LTD. Mới 100%
Expand
Trade date
2026/04/06
B/L No.
108121974110
Suppliers
sichuan xieli parmaceutical.co. ltd
Buyers
công ty cổ phần dược phẩm adlers
POLs
——
PODs
——
Supply area
China
Purchas area
Vietnam
Weight
——
Amount
285
Hs code
29181900
Product tags
chlorflurenol
Product description
Dược chất Ursodeoxycholic Acid, dạng bột, tiêu chuẩn EP12 + Inhouse, dùng để nghiên cứu thuốc dạng viên nang cứng, số lô: C102A260301ZS, NSX: 18/11/2025, Retest: 17/11/2027, mới 100%
Expand
Trade date
2026/03/26
B/L No.
108087177660
Suppliers
sichuan xieli parmaceutical.co. ltd
Buyers
công ty cổ phần dược phẩm bos ton việt nam
POLs
——
PODs
——
Supply area
China
Purchas area
Vietnam
Weight
——
Amount
20150
Hs code
29181900
Product tags
chlorflurenol
Product description
URSODEOXYCHOLIC ACID EP11.8. Nguyên liệu dùng để sản xuất thuốc thuộc mục 31 danh mục 7 TT09. Lô: C092C251209, MFG: 06/12/2025, Retest date: 05/12/2028. Nhà SX: SICHUAN XIELI PHARMACEUTICAL CO., LTD
Expand
Trade date
2026/03/21
B/L No.
108072926400
Suppliers
sichuan xieli parmaceutical.co. ltd
Buyers
công ty tnhh hóa dược hd
Product description
Hóa chất hữu cơ L-tetrahydropalmatine CAS 2934-97-6 để sản xuất L-tetrahydropalmatine hydrosulfate. Hàng có C/O Form E số 02261418200001636. Hàng mới 100 %
Expand
Trade date
2026/03/20
B/L No.
108066609010
Suppliers
sichuan xieli parmaceutical.co. ltd
Buyers
công ty cp xuất nhập khẩu y tế domesco
Product description
Nguyên liệu dùng sản xuất thuốc:HESPERIDIN IN HOUSE ; Lot: C005D250901a ; SX: 08/2025; HD: 08/2028; NSX: Sichuan Xieli Pharmaceutical Co., Ltd. - China
Expand
Trade date
2026/03/20
B/L No.
108066609010
Suppliers
sichuan xieli parmaceutical.co. ltd
Buyers
công ty cp xuất nhập khẩu y tế domesco
POLs
——
PODs
——
Supply area
China
Purchas area
Vietnam
Weight
——
Amount
8837.5
Hs code
29329900
Product tags
——
Product description
Nguyên liệu dùng sản xuất thuốc: DIOSMIN EP11 ; Lot: C006X251204 ;SX: 11/2025; HD: 11/2030; NSX: Sichuan Xieli Pharmaceutical Co., Ltd. - China
Expand
Trade date
2026/03/09
B/L No.
108030349230
Suppliers
sichuan xieli parmaceutical.co. ltd
Buyers
công ty cổ phần dược phẩm savi
sichuan xieli parmaceutical.co. ltd is china Buyer&Supplier,
and primarily engages in the import and export business of products such as chlorflurenol,glycosides,rutoside.
According to the 52wmb.com global trade database, as of 2026-05-21, the company has completed 1321 international trades,
with its main trading regions covering russia,vietnam,colombia etc.
The core products include HS29181900,HS2938100000,HS29389000 etc,
often transported via shanghai,port chengdu, port chengdu cn etc,
and its main trading partners are sanofil aventis de mexico s.a.de c.v.,зао синтез,suan farma s.a..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on sichuan xieli parmaceutical.co. ltd is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.